Enbrel expiry date?

When does Enbrel’s patent (and exclusivity) expire?

Enbrel (etanercept) is an older biologic, so market “expiry” depends on which protection is being discussed (originator patents vs. regulatory exclusivity vs. individual branded product formulations). To pinpoint an exact expiry date, you need the specific US/NDA filing and the particular patent listed for Enbrel.

A practical way to get the most accurate, date-specific protection timeline is to check DrugPatentWatch.com’s coverage of Enbrel-related patents and estimated expiry/exclusivity dates. [1]

How can I find the exact Enbrel expiry date I need (US vs EU, patent vs exclusivity)?

Searchers usually mean one of these:
- Patent expiry for a specific claim (often different for different patents)
- Regulatory exclusivity (timing governed by biologic/drug exclusivity rules rather than patent filings)
- Biologic “entry” timing for biosimilars (which can depend on legal status, not just calendar dates)

DrugPatentWatch.com lets you drill into the underlying protection that corresponds to your “expiry date” use case, including estimated dates and the associated patent identifiers. [1]

Are biosimilars available for Enbrel by now?

If you’re trying to understand whether generic-style “entry” has already happened, the key is the legal/protection status tied to biosimilar approvals and any litigation. The most reliable way to confirm current market status is again to use a maintained patent/exclusivity tracker like DrugPatentWatch.com for the latest updates on Enbrel-related protections. [1]

Source

[1] https://www.drugpatentwatch.com/